Indivior reported 146M in EBIT for its fiscal semester ending in March of 2026.





Ebit Change Date
AstraZeneca USD 3.16B 3.95B Jun/2026
Cassava Sciences USD -11.17M 2.38M Mar/2026
GlaxoSmithKline GBP 2.6B 312M Jun/2026
Glaxosmithkline GBP 2.31B 14.92M Mar/2026
Hikma Pharmaceutical USD 348M 31M Dec/2025
Roche Holding CHF 11.46B 1.91B Jun/2026
West Pharmaceutical Services USD 179.1M 2M Jun/2026